Does High-Dose Antimicrobial Chemotherapy Prevent the Evolution of Resistance?
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Does High-Dose Antimicrobial Chemotherapy Prevent the Evolution of Resistance?
Authors
Keywords
Evolutionary emergence, Therapeutic window method, High-dose chemotherapy, Probability density, Antimicrobial resistance, Drug therapy, Microbial evolution, Evolutionary theory
Journal
PLoS Computational Biology
Volume 12, Issue 1, Pages e1004689
Publisher
Public Library of Science (PLoS)
Online
2016-01-29
DOI
10.1371/journal.pcbi.1004689
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- How to choose the duration of antibiotic therapy in patients with pneumonia
- (2015) Stefano Aliberti et al. CURRENT OPINION IN INFECTIOUS DISEASES
- Trial of Short-Course Antimicrobial Therapy for Intraabdominal Infection
- (2015) Robert G. Sawyer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Applying Pharmacokinetic/Pharmacodynamic Principles in Critically Ill Patients: Optimizing Efficacy and Reducing Resistance Development
- (2015) Mohd Abdul-Aziz et al. SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE
- Is selection relevant in the evolutionary emergence of drug resistance?
- (2015) Troy Day et al. TRENDS IN MICROBIOLOGY
- Rational Design and Adaptive Management of Combination Therapies for Hepatitis C Virus Infection
- (2015) Ruian Ke et al. PLoS Computational Biology
- Low or High Doses of Cefquinome Targeting Low or High Bacterial Inocula Cure Klebsiella pneumoniae Lung Infections but Differentially Impact the Levels of Antibiotic Resistance in Fecal Flora
- (2014) Maleck V. Vasseur et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In VitroResistance Studies with Bacteria That Exhibit Low Mutation Frequencies: Prediction of “Antimutant” Linezolid Concentrations Using a Mixed Inoculum Containing both Susceptible and Resistant Staphylococcus aureus
- (2014) Alexander A. Firsov et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Antibiotics and the gut microbiota
- (2014) Sheetal R. Modi et al. JOURNAL OF CLINICAL INVESTIGATION
- Exploring the collaboration between antibiotics and the immune response in the treatment of acute, self-limiting infections
- (2014) P. Ankomah et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The path of least resistance: aggressive or moderate treatment?
- (2014) R. D. Kouyos et al. PROCEEDINGS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES
- Rapid Response to Selection, Competitive Release and Increased Transmission Potential of Artesunate-Selected Plasmodium chabaudi Malaria Parasites
- (2014) Laura C. Pollitt et al. PLoS Pathogens
- Aggressive Chemotherapy and the Selection of Drug Resistant Pathogens
- (2013) Silvie Huijben et al. PLoS Pathogens
- Correlation between Fecal Concentrations of Ciprofloxacin and Fecal Counts of Resistant Enterobacteriaceae in Piglets Treated with Ciprofloxacin: toward New Means To Control the Spread of Resistance?
- (2012) Thu Thuy Nguyen et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- The Antibiotic Resistance Arrow of Time: Efflux Pump Induction Is a General First Step in the Evolution of Mycobacterial Drug Resistance
- (2012) Aurelia M. Schmalstieg et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Implications of stress-induced genetic variation for minimizing multidrug resistance in bacteria
- (2012) Uri Obolski et al. BMC Medicine
- Testing the mutant selection window in rabbits infected with methicillin-resistant Staphylococcus aureus exposed to vancomycin
- (2012) Y.-l. Zhu et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- “One-Size-Fits-All”? Optimizing Treatment Duration for Bacterial Infections
- (2012) Patricia Geli et al. PLoS One
- Conserving antibiotics for the future: New ways to use old and new drugs from a pharmacokinetic and pharmacodynamic perspective
- (2011) Johan W. Mouton et al. DRUG RESISTANCE UPDATES
- Population biological principles of drug-resistance evolution in infectious diseases
- (2011) Pia Abel zur Wiesch et al. LANCET INFECTIOUS DISEASES
- The dose rate debate: does the risk of fungicide resistance increase or decrease with dose?
- (2011) F. van den Bosch et al. PLANT PATHOLOGY
- The evolution of drug resistance and the curious orthodoxy of aggressive chemotherapy
- (2011) A. F. Read et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Why we should effectively treat malaria
- (2011) Ian M. Hastings TRENDS IN PARASITOLOGY
- Selection of Resistant Bacteria at Very Low Antibiotic Concentrations
- (2011) Erik Gullberg et al. PLoS Pathogens
- Antibiotic resistance—What’s dosing got to do with it?
- (2009) Jason A. Roberts et al. CRITICAL CARE MEDICINE
- A change of strategy in the war on cancer
- (2009) Robert A. Gatenby NATURE
- The Maxwell Finland Lecture: For the Duration-- Rational Antibiotic Administration in an Era of Antimicrobial Resistance and Clostridium difficile
- (2008) L. B. Rice CLINICAL INFECTIOUS DISEASES
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started